An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström Macroglobulinemia
Acerta Pharma BV
Acerta Pharma BV
Cellectar Biosciences, Inc.
M.D. Anderson Cancer Center
University of Washington
Sunnybrook Health Sciences Centre
BeOne Medicines
University of Ulm
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
City of Hope Medical Center
University of Ulm